Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From Sound to Stability: Lessons Learned From the CRUSH Study on Hearing Loss Progression and Vestibular Phenotype in Usher Syndrome Type 2A. | Otol Neurotol | 2026 | 41729786 | PubTator, text mining | PubMed |
| Clinical and Molecular Characteristics of Foveal Sparing Phenotype in Chinese Patients With Inherited Retinal Diseases. | Transl Vis Sci Technol | 2026 | 41700794 | PubTator, text mining | PubMed |
| Characterization of Usher Syndrome Type 2-Associated Proteins in the Retina via Affinity Purification-Mass Spectrometry. | Mol Cell Proteomics | 2026 | 41654259 | PubTator, text mining | PubMed |
| Enhancing Molecular Diagnostic Accuracy in Genetic Eye Disorders Through a Personalized Re-Evaluation Strategy. | Invest Ophthalmol Vis Sci | 2026 | 41615371 | PubTator, text mining | PubMed |
| [Clinical and genetic aspects of inherited retinal dystrophies : Phenotypic and molecular characterization of 1000 IRD patients in a German tertiary referral center]. | Ophthalmologie | 2026 | 41603938 | PubTator, text mining | PubMed |
| Pepino Mosaic Virus: A Globally Important Tomato Pathogen and a Rising Model in Molecular Virology. | Mol Plant Pathol | 2026 | 41603498 | PubTator, text mining | PubMed |
| Stem cell-based therapies for inherited retinal diseases - Translational advances and clinical evidence: A review. | Biomol Biomed | 2026 | 41569064 | PubTator, text mining | PubMed |
| Modulation of Aerobic Glycolysis Genes During the Progression of Retinitis Pigmentosa. | Invest Ophthalmol Vis Sci | 2026 | 41569027 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Factors in Retinitis Pigmentosa: A Retrospective Analysis of a Turkish Patient Cohort. | Med Sci (Basel) | 2026 | 41562913 | PubTator, text mining | PubMed |
| Anatomy- versus Sensitivity-Based Loci Preselection in Detecting USH2A-Retinopathy Microperimetric Progression. | Ophthalmol Sci | 2026 | 41552664 | PubTator, text mining | PubMed |
| Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to target ABCA4 splice variants in Stargardt disease. | Mol Ther Nucleic Acids | 2026 | 41536809 | PubTator, text mining | PubMed |
| Exploring extracellular vesicle MicroRNAs in Usher syndrome type 1B: Tear-Derived EVs as potential indicators of retinal health. | Cell Mol Life Sci | 2026 | 41528484 | PubTator, text mining | PubMed |
| Inherited retinal disorders in Scotland: A 5 year assessment. | Eye (Lond) | 2026 | 41514076 | PubTator, text mining | PubMed |
| Clinical Exome Sequencing: A Genetic Diagnostic Approach for Inherited Retinal Dystrophies. | J Mol Diagn | 2026 | 41500401 | PubTator, text mining | PubMed |
| Benchmarking AlphaMissense against ClinVar for Diagnostic Interpretation of Missense Variants in Inherited Retinal Diseases. | Ophthalmol Sci | 2026 | 41492285 | PubTator, text mining | PubMed |
| Age-Stratified Genetic Spectrum of Retinitis Pigmentosa in Korean Patients: Predominance of RPGR Variants in Early-Onset Disease. | Ann Lab Med | 2026 | 41457516 | PubTator, text mining | PubMed |
| Advances in the genetics of refractive errors: Contributions from the CREAM consortium. | Acta Ophthalmol | 2026 | 41230783 | PubTator, text mining | PubMed |
| Identification of a novel CABP4 frameshift variant and a secondary USH2A missense variant in congenital cone-rod synaptic disorder. | Ophthalmic Genet | 2026 | 41126388 | PubTator, text mining | PubMed |
| AAV-mediated exon skipping therapy for Usher syndrome, type 2A. | Mol Ther | 2026 | 40994011 | PubTator, text mining | PubMed |
| Genetic and clinical characterization of suspected retinitis pigmentosa in a cohort of Brazilian patients. | Mol Vis | 2025 | 41867384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=3